(Q46807629)

25 December 2017

title

Safety and pharmacokinetics of coadministered voriconazole and anidulafungin (English)

1 reference

25 December 2017

1 reference

1 reference

James A Dowell

1

1 reference

25 December 2017

Jennifer Schranz

series ordinal

2

1 reference

25 December 2017

Alice Baruch

series ordinal

3

1 reference

25 December 2017

Grover Foster

series ordinal

4

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

25 December 2017

volume

45

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

1373-1382

1 reference

25 December 2017

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Anidulafungin: review of a new echinocandin antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Voriconazole: A second-generation triazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Histamine H2‐receptor antagonists have no clinically significant effect on the steady‐state pharmacokinetics of voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

Potential for interactions between caspofungin and nelfinavir or rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005281234

21 January 2018

Identifiers

DOI

10.1177/0091270005281234

1 reference

25 December 2017

1 reference

25 December 2017